Molecular basis for exaggerated sensitivity to mexiletine in the cardiac isoform of the fast Na channel.
Cardiac sodium channels have been shown to have a higher sensitivity to local anesthetic agents, such as lidocaine, than the sodium channels of other tissues. To examine if this is also true for mexiletine, we have systematically measured mexiletine sensitivity of the Na channel isoforms, rH1, (mu)1, and rBII, which were transiently expressed in human embryonic kidney (HEK) 293 cells. We confirmed that the cardiac isoform rH1 exhibited the highest sensitivity among the three tested channel isoforms. In rH1, (mu)1, and rBII, the respective IC(50) values were 62, 294, and 308 microM mexiletine, in regard to tonic block, and 18, 54, and 268 microM mexiletine, in relation to use (8 Hz)-dependent block. The relatively high drug sensitivity of rH1 was an invariant finding, irrespective of channel state or whether channels were subjected to infrequent or frequent depolarizing stimuli. Mutating specific amino acids in the skeletal muscle isoform (mu)1 (namely, (mu)1-I433V and (mu)1-S251A) to those of the cardiac isoform at putative binding sites for local anesthetic agents revealed that only one of the point mutations ((mu)1-S251A) has relevance to the high cardiac drug sensitivity, because mexiletine produced significantly more use-dependent and tonic block in (mu)1-S251A than wild-type (mu)1.
Kawagoe
Hiroyuki
H
Department of Physiology, School of Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, 734-8551, Hiroshima, Japan.
Yamaoka
Kaoru
K
Kinoshita
Eiji
E
Fujimoto
Yoshinori
Y
Maejima
Hiroshi
H
Yuki
Tsunetsugu
T
Seyama
Issei
I
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D002478:Cells, Cultured; D004347:Drug Interactions; D004594:Electrophysiology; D006801:Humans; D008801:Mexiletine / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D020033:Protein Isoforms / Q000187:drug effects / Q000378:metabolism; D026941:Sodium Channel Blockers / Q000494:pharmacology*; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism*
D000889:Anti-Arrhythmia Agents; D020033:Protein Isoforms; D026941:Sodium Channel Blockers; D015222:Sodium Channels; D008801:Mexiletine